University of Toronto
U of T epidemiologist leads study tracking COVID-19 immunity of 10,000 Canadians
June 1, 2020
A proprietary opinion and insight community we've built from the ground up.
Learn about the Angus Reid Group
Work with Angus Reid
Learn about our leadership team
Here's what we're thinking
News coverage and press releases
This blog post originally ran in QCRA Views. You can read the unabridged version, with...
Trusting your data sources is the first step.
We're experts in your business.
Tapping into Gen-Z and Millennials to Understand the Impact of Community
Thought Leadership and Partnerships
Research in action
Reports, Whitepapers and Research
At the height of the pandemic, ARG had to deliver data about incidence rates and the prevalence of COVID-19 antibodies in the Canadian population.
Over 10,000 Canadians participated in the landmark study, sharing their most personal data: blood samples. Crucial health data informed public policy in Canada, and the results were published in the New England Journal of Medicine.
Early in the COVID-19 pandemic, the Angus Reid Group partnered with the Centre for Global Health Research, Unity Health Toronto, and the University of Toronto to launch the Action to Beat Coronavirus study (ABC) – a landmark effort in the race to understand what the pandemic meant for Canadians, and the world.
The study would provide crucial information on the course of the COVID-19 pandemic in Canada over time, with periodic survey questionnaires and blood testing for COVID-19 antibodies among a representative sample of adult Canadians sourced from the Angus Reid Forum.
The ABC study conducted five waves of research among the Canadian population, drawing critical insights about the prevalence of antibodies and the spread of COVID-19 in Canada. This research pointed to Canada having among the lowest national rates of infection/prevalence of antibodies early in the pandemic with approximately 2% of Angus Reid Forum members being positive for antibodies. Other nations ranged from about 1% in Iceland, to over 9% in the United States at that time.
The study also noted that about 30% of those with positive blood antibody tests did not report symptoms, confirming that asymptomatic infections were, and are, common.
The study ultimately informed public health policy in Canada, shed light on prevalence and spread of the COVID-19 virus in this country, and established valuable data for comparison against other nations. Results from the study were published in the New England Journal of Medicine, citing Angus Reid Group researchers among the authors.
The ABC study reached Canadians in nine provinces and one territory, mailing out 32,000 sample kits and processing over 20,000 self-administered blood sample collections.
University of Toronto
June 1, 2020
Dalla Lana School of Public Health
May 19, 2022